SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.791311
Abstract: Lin et al. recently did a network meta-analysis based on cardiovascular (CV) outcome trials (CVOTs) of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and those of glucagon-like peptide-1 receptor agonists (GLP1RAs). Due to the absence of CVOTs… read more here.
Keywords: sglt2is glp1ras; cause mortality; sglt2is; meta analysis ... See more keywords